Christos Laganas

Christos Laganas

Auto-generated profile, based on publicly available information

Christos Laganas

Department of Electrical and Computer Engineering, Aristotle University of Thessaloniki, Greece

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Open access
CLChristos Laganas
Christos Laganas
DIDimitrios Iakovakis
Dimitrios Iakovakis
SHStelios Hadjidimitriou
Stelios Hadjidimitriou
VCVasileios Charisis
Vasileios Charisis
SDSofia Balula Dias
Sofia Balula Dias
LHLeontios Hadjileontiadis
Leontios Hadjileontiadis
Objective: Parkinson’s Disease (PD) is a progressive neurodegenerative disorder, manifesting with subtle early signs, which, often hinder timely and early diagnosis and treatment. The development of accessible, technology-based methods for longitudinal PD symptoms tracking in daily living, offers the potential for transforming disease assessment and accelerating diagnosis. Methods: A privacy-aware method for classifying patients and healthy controls (HC), on the grounds of speech impairment present in PD, is proposed. Voice features from running speech signals were extracted from passively-captured recordings over voice calls. Language-aware training of multiple- and single-instance learning classifiers was employed to fuse and predict on voice features and demographic data from a multilingual cohort of 498 subjects (392/106 self-reported HC/PD patients). Results: By means of leave-one-subject-out cross-validation, the best-performing models yielded 0.69/0.68/0.63/0.83 area under the Receiver Operating Characteristic curve (AUC) for the binary classification of PD patient vs. HC in sub-cohorts of English/Greek/German/Portuguese-speaking subjects, respectively. Out-of sample testing of the best performing models was conducted in an additional dataset, generated by 63 clinically-assessed subjects (24/39 HC/early PD patients). Testing has resulted in 0.84/0.93/0.83 AUC for the English/Greek/German-speaking sub-cohorts, respectively. Conclusions: The proposed approach outperforms other methods proposed for language-aware PD detection considering the ecological validity of the voice data. Significance: This paper introduces for the first time a high-frequency, privacy-aware and unobtrusive PD screening tool based on analysis of voice samples captured during routine phone calls.